Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
DUBLIN, March 6, 2024 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 26th annual Barclays global healthcare conference on Tuesday, March 12, 2024.
Karen Parkhill, Medtronic executive vice president and chief financial officer, will answer questions on the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT).
A live webcast of the Q&A session will be available on March 12, 2024, by clicking on the Events link at http://investorrelations.
LATEST
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09